Organisation paid for research Program year 2025 Source: CMS Open Payments

Clinical Trials, Inc.

Neither a doctor nor a teaching hospital

Research payments

$145,790

45 payments

Through program year 2025, Clinical Trials, Inc. is reported as receiving $145,790 in research payments, across 45 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$533	1
2023	Research	$2,197	1
2020	Research	$77,621	35
2019	Research	$65,438	8

Breakdown

Who paid Research payments · program years 2019–2025

SK Life Science, Inc. $72,824 32 payments
Eisai Inc. $60,438 7 payments
Avanir Pharmaceuticals, Inc. $9,797 4 payments
UCB Biosciences Inc. $2,197 1 payment
Ucb SA $533 1 payment

Studies the money was for Research payments · program years 2019–2025

A Multicenter, Double-Blind, Randomized, Crossover, Single-Dose Study With An Open-Label Treatment Period Evaluating Pharmacodynamic Activity of E2082 in Adult Subjects With Photosensitive Epilepsy $51,865 4 payments
59566 $26,572 5 payments
45569 $10,138 2 payments
Ykp3089c013 $9,918 19 payments
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects with Partial Onset Seizures $9,882 1 payment
17-Avp-786-305 $9,797 4 payments
A Multicenter, Double-Blind, Randomized, Cross-Over Study Evaluating Pharmacodynamic Activity of E2730 in Adult Subjects With Photosensitive Epilepsy $8,573 3 payments
1-Fa7759 $7,475 2 payments
045569 $5,895 2 payments
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects with Partial Onset Seizures, with Optional Open-Label Extension $2,946 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.